Somnomed Limited Stock Market Value
SOMNF Stock | USD 0.17 0.01 5.56% |
Symbol | SomnoMed |
SomnoMed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SomnoMed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SomnoMed.
10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in SomnoMed on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding SomnoMed Limited or generate 0.0% return on investment in SomnoMed over 30 days. SomnoMed is related to or competes with Medtronic PLC, CONMED, Glaukos Corp, Integer Holdings, Orthopediatrics Corp, LivaNova PLC, and Paragon 28. SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment o... More
SomnoMed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SomnoMed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SomnoMed Limited upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | 0.0124 | |||
Maximum Drawdown | 103.99 |
SomnoMed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SomnoMed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SomnoMed's standard deviation. In reality, there are many statistical measures that can use SomnoMed historical prices to predict the future SomnoMed's volatility.Risk Adjusted Performance | 0.0288 | |||
Jensen Alpha | 0.1098 | |||
Total Risk Alpha | (1.49) | |||
Treynor Ratio | 0.2228 |
SomnoMed Limited Backtested Returns
SomnoMed appears to be out of control, given 3 months investment horizon. SomnoMed Limited owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.026, which indicates the firm had a 0.026% return per unit of risk over the last 3 months. We have found twenty technical indicators for SomnoMed Limited, which you can use to evaluate the volatility of the company. Please review SomnoMed's Variance of 109.06, coefficient of variation of 3911.53, and Risk Adjusted Performance of 0.0288 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, SomnoMed holds a performance score of 2. The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, SomnoMed will likely underperform. Please check SomnoMed's information ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether SomnoMed's existing price patterns will revert.
Auto-correlation | -0.35 |
Poor reverse predictability
SomnoMed Limited has poor reverse predictability. Overlapping area represents the amount of predictability between SomnoMed time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SomnoMed Limited price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current SomnoMed price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.35 | |
Spearman Rank Test | -0.19 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
SomnoMed Limited lagged returns against current returns
Autocorrelation, which is SomnoMed pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SomnoMed's pink sheet expected returns. We can calculate the autocorrelation of SomnoMed returns to help us make a trade decision. For example, suppose you find that SomnoMed has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
SomnoMed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SomnoMed pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SomnoMed pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SomnoMed pink sheet over time.
Current vs Lagged Prices |
Timeline |
SomnoMed Lagged Returns
When evaluating SomnoMed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SomnoMed pink sheet have on its future price. SomnoMed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SomnoMed autocorrelation shows the relationship between SomnoMed pink sheet current value and its past values and can show if there is a momentum factor associated with investing in SomnoMed Limited.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in SomnoMed Pink Sheet
SomnoMed financial ratios help investors to determine whether SomnoMed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SomnoMed with respect to the benefits of owning SomnoMed security.